Presurgical Medical Treatment in Prolactinomas: Surgical Implications and Pathological Characteristics from 290 Cases.
Zhengyuan ChenXuefei ShouLijin JiHaixia ChengMing ShenZengyi MaWenqiang HeZhao YeYichao ZhangNidan QiaoQilin ZhangYongfei WangPublished in: The Journal of clinical endocrinology and metabolism (2024)
This study described increased surgical difficulty and inferior endocrine outcomes which associated with tumor fibrosis secondary to presurgical BRC treatment in prolactinomas. Neurosurgeons should be noticed that presurgical BRC treatment may render subsequent surgery more challenging.